Stuart Rose

Stuart has over 30 years’ experience in life sciences spanning global pharma, an Oxford university spin-out, mid cap biopharma, privately-owned SMEs, strategic consulting, advising PE & VC investors and leadership of a not-for-profit organisation. Latterly he spent 13 years as Managing Director for Merz Pharma UK, building the business up to be one of the top performing affiliates globally. He joined OBN as Chief Executive in May 2022.